105 related articles for article (PubMed ID: 2066699)
1. Effects of insulin-like growth factor-II on growth hormone release from human somatotrophinoma cells in vitro.
Harris PE; Daniels M; James RA; Turner SJ; Dewar J; Kendall-Taylor P
J Endocrinol; 1991 Jun; 129(3):447-51. PubMed ID: 2066699
[TBL] [Abstract][Full Text] [Related]
2. Effects of insulin-like growth factor-I on growth hormone and prolactin secretion and cell proliferation of human somatotrophinomas and prolactinomas in vitro.
Atkin SL; Landolt AM; Foy P; Jeffreys RV; Hipkin L; White MC
Clin Endocrinol (Oxf); 1994 Oct; 41(4):503-9. PubMed ID: 7525124
[TBL] [Abstract][Full Text] [Related]
3. Effects of recombinant human activin A on growth hormone secretion by human somatotrophinomas in vitro.
Daniels M; Harris PE; James RA; Turner SJ; Dewar JH; Kendall-Taylor P
J Endocrinol; 1993 May; 137(2):329-34. PubMed ID: 8326258
[TBL] [Abstract][Full Text] [Related]
4. Effects of growth hormone-releasing factor (1-44) on growth hormone release from human somatotrophinomas in vitro: interaction with somatostatin, dopamine, vasoactive intestinal peptide and cycloheximide.
White MC; Daniels M; Kendall-Taylor P; Turner SJ; Mathias D; Teasdale G
J Endocrinol; 1985 May; 105(2):269-76. PubMed ID: 2859345
[TBL] [Abstract][Full Text] [Related]
5. Actions of L-363,586, a cyclic hexapeptide analogue of somatostatin, on GH secretion by human somatotrophinoma cells in vitro.
Daniels M; James RA; Harris PE; Turner SJ; Dewar J; Kendall-Taylor P
Life Sci; 1991; 49(16):1207-12. PubMed ID: 1680212
[TBL] [Abstract][Full Text] [Related]
6. Long-term in-vitro maintenance of growth hormone secretion from human somatotrophinomas with cortisol, and its effects on growth hormone-releasing factor.
Daniels M; White MC; Kendall-Taylor P
J Endocrinol; 1987 Sep; 114(3):503-9. PubMed ID: 3117958
[TBL] [Abstract][Full Text] [Related]
7. The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II.
Ceda GP; Davis RG; Rosenfeld RG; Hoffman AR
Endocrinology; 1987 Apr; 120(4):1658-62. PubMed ID: 3104015
[TBL] [Abstract][Full Text] [Related]
8. A close correlation between the inhibitory effects of insulin-like growth factor-I and SMS 201-995 on growth hormone release by acromegalic pituitary tumours in vitro and in vivo.
Lamberts SW; van Koetsveld P; Hofland L
Clin Endocrinol (Oxf); 1989 Oct; 31(4):401-10. PubMed ID: 2627746
[TBL] [Abstract][Full Text] [Related]
9. Relationship between protein kinase C and adenylyl cyclase activity in the regulation of growth hormone secretion by human pituitary somatotrophinomas.
Lei T; Adams EF; Buchfelder M; Fahlbusch R
Neurosurgery; 1996 Sep; 39(3):569-75; discussion 575-6. PubMed ID: 8875488
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor I disparately regulates prolactin and growth hormone synthesis and secretion: studies using the teleost pituitary model.
Fruchtman S; Jackson L; Borski R
Endocrinology; 2000 Aug; 141(8):2886-94. PubMed ID: 10919276
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the novel GH secretagogue hexarelin with GHRH in regulating the secretion of GH by cultured human pituitary somatotrophinomas in vitro.
Liu Q; Lei T; Liu K; Lin W; Adams EF
J Tongji Med Univ; 2000; 20(2):109-11. PubMed ID: 12845719
[TBL] [Abstract][Full Text] [Related]
12. Phorbol ester, not growth hormone releasing factor, consistently stimulates growth hormone release from somatotroph adenomas in culture.
Emoto N; Ohmura E; Isozaki O; Tsushima T; Shizume K; Demura H
Clin Endocrinol (Oxf); 1991 May; 34(5):377-82. PubMed ID: 2060147
[TBL] [Abstract][Full Text] [Related]
13. Role of insulin-like growth factor I in regulating growth hormone release and feedback in the male rat.
Becker K; Stegenga S; Conway S
Neuroendocrinology; 1995 May; 61(5):573-83. PubMed ID: 7617136
[TBL] [Abstract][Full Text] [Related]
14. In vitro regulation of growth hormone (GH) release from ovine pituitary cells during fetal and neonatal development: effects of GH-releasing factor, somatostatin, and insulin-like growth factor I.
Blanchard MM; Goodyer CG; Charrier J; Barenton B
Endocrinology; 1988 May; 122(5):2114-20. PubMed ID: 2896119
[TBL] [Abstract][Full Text] [Related]
15. The interrelationship between the effects of insulin-like growth factor I and somatostatin on growth hormone secretion by normal rat pituitary cells: the role of glucocorticoids.
Lamberts SW; den Holder F; Hofland LJ
Endocrinology; 1989 Feb; 124(2):905-11. PubMed ID: 2492219
[TBL] [Abstract][Full Text] [Related]
16. Rapid suppressing action of insulin-like growth factor-I (IGF-I) on GH release from anterior pituitary cells of goats.
Katoh K; Shimoguchi R; Ishiwata H; Obara Y
Domest Anim Endocrinol; 2004 Apr; 26(3):177-88. PubMed ID: 15036373
[TBL] [Abstract][Full Text] [Related]
17. Regulation of growth hormone (GH) secretion by GH-releasing factor, somatostatin, and insulin-like growth factor I in ovine fetal and neonatal pituitary cells in vitro.
Silverman BL; Bettendorf M; Kaplan SL; Grumbach MM; Miller WL
Endocrinology; 1989 Jan; 124(1):84-9. PubMed ID: 2562828
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor inhibition of growth hormone secretion.
Sheppard MS; Bala RM
Can J Physiol Pharmacol; 1986 May; 64(5):525-30. PubMed ID: 2425915
[TBL] [Abstract][Full Text] [Related]
19. Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours.
Szepeshazi K; Schally AV; Groot K; Armatis P; Hebert F; Halmos G
Eur J Cancer; 2000 Jan; 36(1):128-36. PubMed ID: 10741306
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of stimulatory G protein alpha-subunit is a hallmark of most human somatotrophic pituitary tumours and is associated with resistance to GH-releasing hormone.
Hamacher C; Bröcker M; Adams EF; Lei T; Fahlbusch R; Buchfelder M; Derwahl M
Pituitary; 1998 Apr; 1(1):13-23. PubMed ID: 11081179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
